Similar articles

• Lessons from the cardiac arrhythmia suppression trial.

  Garratt C, Ward DE, Camm AJ. Garratt C, et al. BMJ. 1989 Sep 30;299(6703):805-6. doi: 10.1136/bmj.299.6703.805. BMJ. 1989. PMID: 2510839 Free PMC article. Clinical Trial. No abstract available.
• Flecainide and CAST.

  [No authors listed] [No authors listed] Lancet. 1989 Aug 26;2(8661):481-2. Lancet. 1989. PMID: 2570188 Clinical Trial. No abstract available.
• Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.

  Cardiac Arrhythmia Pilot Study (CAPS) Investigators. Cardiac Arrhythmia Pilot Study (CAPS) Investigators. Am J Cardiol. 1988 Mar 1;61(8):501-9. doi: 10.1016/0002-9149(88)90754-0. Am J Cardiol. 1988. PMID: 2894169 Clinical Trial.
• CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

  Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ, et al. Akhtar M, et al. Circulation. 1990 Mar;81(3):1123-7. doi: 10.1161/01.cir.81.3.1123. Circulation. 1990. PMID: 1689621 Review. No abstract available.
• The clinical use of class IC antiarrhythmic drugs.

  Abi Samra F. Abi Samra F. J La State Med Soc. 1989 May;141(5):27-31. J La State Med Soc. 1989. PMID: 2499646 Review.